Paper41864914
Efficacy and long-term engagement of a WeChat-integrated modality versus a traditional quitline on smoking cessation in China: a randomised controlled trial.
Chu S and 5 others. BMC Med, 2026. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Efficacy and long-term engagement of a WeChat-integrated modality versus a traditional quitline on smoking cessation in China: a randomised controlled trial. Papers, record 41864914. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41864914
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Efficacy and long-term engagement of a WeChat-integrated modality versus a traditional quitline on smoking cessation in China: a randomised controlled trial.
- PubMed
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Smoking Cessation | Major topic |
| Social Media | Major topic |
| Hotlines | Major topic |
| Humans | |
| Adult | |
| Female | |
| China | |
| Male | |
| Middle Aged | |
| Treatment Outcome | |
| Counseling |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| CFH 2024-1G-1062 | Capital's Funds for Health Improvement and Research | PubMed | ||
| ysbz2022002 | Financial Budgeting Project of Beijing Institute of Respiratory Medicine | PubMed |
Source PubMed
References50
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 27207211 | Text Messaging-Based Interventions for Smoking Cessation: A Systematic Review and Meta-Analysis. | JMIR Mhealth Uhealth | 2016 | https://conductscience.org/library/papers/27207211 | PubMed |
| 2 | 34472676 | Effectiveness of an optimized text message and Internet intervention for smoking cessation: A randomized controlled trial. | Addiction | 2022 | https://conductscience.org/library/papers/34472676 | PubMed |
| 3 | 32195370 | A randomized controlled trial of a smoking cessation smartphone application with a carbon monoxide checker. | NPJ Digit Med | 2020 | https://conductscience.org/library/papers/32195370 | PubMed |
| 4 | 34051921 | Spatial, temporal, and demographic patterns in prevalence of smoking tobacco use and initiation among young people in 204 countries and territories, 1990-2019. | Lancet Public Health | 2021 | https://conductscience.org/library/papers/34051921 | PubMed |
| 5 | 36964513 | Evaluation of an innovative mHealth-based integrated modality for smoking cessation in Chinese smokers: protocol for a randomized controlled trial. | BMC Public Health | 2023 | https://conductscience.org/library/papers/36964513 | PubMed |
| 6 | 33095184 | Mobile Social Network-Based Smoking Cessation Intervention for Chinese Male Smokers: Pilot Randomized Controlled Trial. | JMIR Mhealth Uhealth | 2020 | https://conductscience.org/library/papers/33095184 | PubMed |
| 7 | 19246437 | The accuracy of self-reported smoking: a systematic review of the relationship between self-reported and cotinine-assessed smoking status. | Nicotine Tob Res | 2009 | https://conductscience.org/library/papers/19246437 | PubMed |
| 8 | 37251625 | Efficacy of WeChat-based online smoking cessation intervention ('WeChat WeQuit') in China: a randomised controlled trial. | EClinicalMedicine | 2023 | https://conductscience.org/library/papers/37251625 | PubMed |
| 9 | 37405266 | Effectiveness and Acceptability of a Comprehensive Mobile Health-Based Modality for Smoking Cessation - Beijing Municipality, China, 2022. | China CDC Wkly | 2023 | https://conductscience.org/library/papers/37405266 | PubMed |
| 10 | 33927586 | Mobile chat-based support plus nicotine replacement therapy sampling to promote smoking cessation for community smokers: A randomized controlled trial. | Tob Induc Dis | 2021 | https://conductscience.org/library/papers/33927586 | PubMed |
| 11 | 36130170 | Facebook Intervention to Connect Alaska Native People With Resources and Support to Quit Smoking: CAN Quit Pilot Randomized Controlled Trial. | Nicotine Tob Res | 2023 | https://conductscience.org/library/papers/36130170 | PubMed |
| 12 | 36857056 | Assessment of a Text Message-Based Smoking Cessation Intervention for Adult Smokers in China: A Randomized Clinical Trial. | JAMA Netw Open | 2023 | https://conductscience.org/library/papers/36857056 | PubMed |
| 13 | 29797621 | A randomized controlled evaluation of the tobacco status project, a Facebook intervention for young adults. | Addiction | 2018 | https://conductscience.org/library/papers/29797621 | PubMed |
| 14 | 16567055 | The psychometric properties of the Chinese version of the Fagerstrom Test for Nicotine Dependence. | Addict Behav | 2006 | https://conductscience.org/library/papers/16567055 | PubMed |
| 15 | 37625030 | Effective Behavior Change Techniques in Digital Health Interventions for the Prevention or Management of Noncommunicable Diseases: An Umbrella Review. | Ann Behav Med | 2023 | https://conductscience.org/library/papers/37625030 | PubMed |
| 16 | 40621203 | Smoking Prevalence in Urban and Rural Areas - China, 2024. | China CDC Wkly | 2025 | https://conductscience.org/library/papers/40621203 | PubMed |
| 17 | 38855571 | Comparative Effectiveness of Mobile Health-Based Comprehensive Smoking Cessation Modalities and Traditional Clinic-Delivered Treatments - Beijing Municipality, China, May 2022 to April 2024. | China CDC Wkly | 2024 | https://conductscience.org/library/papers/38855571 | PubMed |
| 18 | 26928205 | Randomised controlled trial evaluation of Tweet2Quit: a social network quit-smoking intervention. | Tob Control | 2017 | https://conductscience.org/library/papers/26928205 | PubMed |
| 19 | 25006045 | Intermediate cessation outcomes among quitline callers during a national tobacco education campaign. | Nicotine Tob Res | 2014 | https://conductscience.org/library/papers/25006045 | PubMed |
| 20 | 28239919 | Large multi-centre pilot randomized controlled trial testing a low-cost, tailored, self-help smoking cessation text message intervention for pregnant smokers (MiQuit). | Addiction | 2017 | https://conductscience.org/library/papers/28239919 | PubMed |
Data1
The data bank entries PubMed's record names. Trial numbers are under Trials.
| Data bank | Accession |
|---|---|
| ChiCTR | ChiCTR2200066427 |
Source PubMed
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41864914
GET https://conductscience.org/api/papers/v1/41864914/references?page=2